CANCER STEM CELLS

Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics
https://www.ncbi.nlm.nih.gov/pubmed/29236307

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signaling
https://www.ncbi.nlm.nih.gov/pubmed/28553931

IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells
https://www.ncbi.nlm.nih.gov/pubmed/27533463

Targeting of IL-4 and IL-13 receptors for cancer therapy
http://www.ncbi.nlm.nih.gov/pubmed/26088753

Crucial role of interleukin-4 in the survival of colon cancer stem cells
http://www.ncbi.nlm.nih.gov/pubmed/18519657

Survivin Is Regulated by Interleukin-4 in Colon Cancer Stem Cells
http://www.ncbi.nlm.nih.gov/pubmed/20506498

Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
http://www.ncbi.nlm.nih.gov/pubmed/18371377

IL-4-mediated drug resistance in colon cancer stem cells
http://www.ncbi.nlm.nih.gov/pubmed/18235245

Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4
http://www.ncbi.nlm.nih.gov/pubmed/24277698